Notably, mutation of HRK1 not only suppressed azole-resistance of the hog1Δ mutant, but also further increased azole-sensitivity compared to the wild-type, strongly suggesting a novel drug target for treatment of cryptococcosis. This evidence concerns the gene KCNJ4 and cryptococcosis.